市场调查报告书
商品编码
1371966
2030 年脑机介面 (BCI) 市场预测:按组件、类型、应用、最终用户和地区分類的全球分析Brain Computer Interface Market Forecasts to 2030 - Global Analysis By Component, Type, Application, End User and By Geography. |
根据Stratistics MRC预测,2023年全球脑机介面(BCI)市场规模将达到20.7亿美元,预计在预测期内将以19.5%的复合年增长率成长,到2030年达到72.3亿美元。
脑机介面(BCI),又称神经控制介面(NCI)、心机介面(MMI)、直接神经介面(DNI)、脑机介面(BMI)、脑机接口,是一种直接从大脑到外部设备的连接。实现通讯的平台。为了记录人脑发出的电脉衝,脑机介面系统能够执行磁振造影.整合影像方法。
根据世界卫生组织的报告,到2030年,大约有8,200万人将受到失智症的影响,到2050年,这一数字将达到1.52亿。这显示了未来年度BCI的潜在需求。
阿兹海默症和帕金森氏症等神经退化性疾病的日益普及对脑机介面(BCI)市场产生了重大影响。这些疾病逐渐降低认知和运动功能,使其难以与环境有效沟通和互动。由于人口高龄化和诊断方法的改进,全球神经退化性疾病的盛行率持续增加,对先进脑机介面的需求不断增加。此外,BCI 技术的创新,例如先进的讯号处理、机器学习演算法和小型化植入物,对于满足神经退化性疾病影响的个体的特定需求至关重要,而这群患者正在推动BCI 市场的增长和发展容纳增加的
脑机介面(BCI)技术的高成本是BCI市场的主要抑制因素。复杂的研发和製造流程导致成本上升。这些成本转嫁给消费者,限制了普及和可近性,特别是对于经济能力较差的个人而言。此外,保险往往不承保,并且可能没有足够的支持来实施 BCI。因此,这种最尖端科技对于许多潜在用户来说是遥不可及的,阻碍了其更广泛的普及并阻碍了市场的潜在成长。
医疗保健设施的快速扩张和进步为脑机介面(BCI)市场创造了巨大的机会。随着对精准医疗和个体化医疗保健的日益关注,BCI 提供了一种创新手段来改善诊断、治疗和患者照护。将脑机介面纳入医疗保健系统将能够即时监测神经活动,促进各种神经系统疾病的早期发现和介入。此外,医疗机构和 BCI 开发商之间的合作允许根据特定的医疗要求客製化 BCI 解决方案。医疗保健和 BCI 之间的共生关係具有巨大的潜力,可以改变患者的治疗结果,并促进 BCI 的持续发展和整合主流医学。
缺乏熟练的专业人员对脑机介面(BCI)市场构成了重大威胁。开发和操作 BCI 需要多个领域的专业知识,包括神经科学、工程、讯号处理和机器学习。然而,这些领域的专家却很短缺。这种短缺限制了 BCI 技术的研究、创新和有效实施的步伐。此外,脑机介面的复杂性需要专门的培训,这使得医疗保健提供者和技术人员很难实施和最佳利用这些技术。因此,它阻碍了市场的成长。
COVID-19造成的景气衰退对世界各地的产业产生了重大影响,但科技业受危机的影响比其他经济领域小一些。疫情也造成经济低迷,迫使世界各地的各类企业做出剧烈且迅速的业务变革。支援人工智慧和物联网等最尖端科技普及的发展也有所增加。此外,在COVID-19大流行期间,已经实施脑机介面的组织能够快速适应新病毒,因为人机接触较少,而医疗保健领域的发展使组织能够快速适应新病毒病毒。能够满足业务需求。脑机介面可以帮助企业应对当前的流行病并继续盈利运作。
预计侵入式脑机介面领域将占最大份额。这涉及将电极直接植入大脑以建立精确、高保真的神经介面。这种方法提供了无与伦比的准确性和资料分辨率,使其成为神经修復和运动功能恢復等复杂应用的理想选择。此外,随着手术技术、材料和讯号处理演算法的进步,侵入式脑机介面领域不断发展。该领域正在进行的研究和创新在增强侵入式脑机介面的能力和扩展其潜在应用方面具有巨大的潜力。因此,该行业的成长需求正在增加。
预计硬体产业在预测期内将出现良好成长。脑机介面 (BCI) 市场的硬体部分包括 BCI 系统有效运作所必需的实体组件。这包括电极、感测器、放大器、讯号处理设备、输出设备等。电极在捕捉神经讯号方面发挥关键作用,感测器确保准确的资料收集。放大器还增强这些讯号并对其进行处理以进行分析。讯号处理单元解释神经资料,输出装置传达 BCI 系统产生的回馈和动作。此外,硬体技术、小型化和材料改进的持续进步使 BCI 更加高效、舒适和耐用,有助于 BCI 在各种应用和行业中的整体成长和采用。
在估计期间,亚太地区占据最大的市场占有率。由于政府资助的增加以及为寻找脑部疾病和损伤的治疗方法而进行的大量研究,亚太地区的脑机介面市场正在扩大。此外,负担得起的製造地点和有吸引力的税收制度正在鼓励外国公司投资亚洲国家这个利润丰厚的产业。这大大鼓励了脑机介面产业在该领域的拓展。此外,亚太地区脑机介面市场公司之间日益加强的合作最终推动了脑机介面市场的成长。
预计北美在预测期内将实现盈利成长。北美国家正积极进行脑机介面(BCI)技术的研发和临床试验。高昂的研发费用、最先进的基础设施建设以及最尖端科技的有效利用是推动北美地区脑机介面市场扩张的主要原因。帕金森氏症、亨廷顿氏症和阿兹海默症神经系统疾病的发生率预计也将推动市场扩张。此外,随着脑机介面的改进等最尖端科技的发展,逼真游戏的受欢迎程度和需求预计将会增加。这将加速 BCI 技术在美国、加拿大和其他北美国家的采用。
According to Stratistics MRC, the Global Brain Computer Interface Market is accounted for $2.07 billion in 2023 and is expected to reach $7.23 billion by 2030 growing at a CAGR of 19.5% during the forecast period. A brain-computer interface (BCI), also referred to as a neural-control interface (NCI), mind-machine interface (MMI), direct neural interface (DNI), brain-machine interface (BMI), or brain-machine interface, is a platform that allows for direct brain-to-external device communication. In order to record the electrical impulses sent by the human brain, brain machine interface systems integrate brain imaging methods such as magnetoencephalography (MEG), functional magnetic resonance imaging (fMRI), electrocorticography (ECOG), and electroencephalography (EEG).
According to the WHO report, around 82 million people will be affected by dementia by 2030 and this number will reach 152 million by 2050. This shows the potential demand for BCI in the coming years.
The rising incidence of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, is significantly impacting the Brain-Computer Interface (BCI) market. These disorders cause a gradual decline in cognitive and motor functions, making it challenging for individuals to communicate or interact with their environment effectively. As the prevalence of neurodegenerative disorders continues to grow globally due to ageing populations and improved diagnostics, the demand for advanced BCIs is on the rise. Furthermore, innovations in BCI technology, including enhanced signal processing, machine learning algorithms, and miniaturised implants, are crucial in addressing the specific needs of individuals affected by neurodegenerative disorders, fuelling the growth and evolution of the BCI market to cater to this growing patient population.
The high cost associated with Brain-Computer Interface (BCI) technology serves as a significant restraint in the BCI market. The intricate research, development, and manufacturing processes involved contribute to the elevated expenses. These costs are then passed on to consumers, limiting widespread adoption and accessibility, especially for individuals with limited financial resources. Insurance coverage often falls short of adequately supporting BCI acquisitions. As a result, many potential users are unable to afford this cutting-edge technology, impeding its broader adoption and hindering the market's potential growth.
The rapid expansion and advancement of healthcare facilities present a substantial opportunity for the Brain-Computer Interface (BCI) market. With an increasing focus on precision medicine and personalised healthcare, BCIs offer an innovative avenue for improved diagnosis, treatment, and patient care. The integration of BCIs within healthcare systems allows for real-time monitoring of neural activities, facilitating early detection and intervention in various neurological disorders. Moreover, the collaboration between healthcare facilities and BCI developers enables the customization of BCI solutions to align with specific medical requirements. The symbiotic relationship between healthcare and BCIs holds immense potential to transform patient outcomes and drive the continued growth and integration of BCIs into mainstream healthcare practices.
The dearth of skilled professionals poses a significant threat to the Brain-Computer Interface (BCI) market. Developing and operating BCIs requires expertise in multiple disciplines, such as neuroscience, engineering, signal processing, and machine learning. However, there's a shortage of professionals proficient in these areas. This scarcity limits the pace of research, innovation, and effective implementation of BCI technology. Additionally, the intricate nature of BCIs necessitates specialised training, making it challenging for healthcare providers and technicians to adopt and utilise these technologies optimally. Thus, it is hampering market growth.
The COVID-19-induced recession is having a significant impact on industries all around the world; however, the technology industry was somewhat less affected by the crisis than the rest of the economy was. Also, the pandemic has caused a recession in the economy that has forced various enterprises across the globe to dramatically and rapidly shift their operations. There have been more developments that support the spread of cutting-edge technology like artificial intelligence and the internet of things. Moreover, due to less human-to-machine contact during the COVID-19 pandemic, organisations that had already implemented brain-computer interfaces were able to quickly adapt to the new virus variant, meeting business requirements that were brought about by developments in the healthcare sector. Brain-computer interfaces assist firms in managing the ongoing pandemic and continuing to operate profitably.
The Invasive brain computer interface segment is estimated to hold the largest share. It involves implanting electrodes directly into the brain to establish a precise and high-fidelity neural interface. This approach provides unparalleled accuracy and data resolution, making it ideal for complex applications such as neuroprosthetics and restoring motor functions. Moreover, the invasive BCI segment continues to evolve with advancements in surgical techniques, materials, and signal processing algorithms. Ongoing research and innovations in this domain hold immense promise for enhancing the capabilities and expanding the potential applications of invasive BCIs. Hence, there is an increasing demand for segment growth.
The Hardware segment is anticipated to have lucrative growth during the forecast period. The hardware segment of the Brain-Computer Interface (BCI) market encompasses the essential physical components needed for BCI systems to function effectively. This includes electrodes, sensors, amplifiers, signal processing units, and output devices. Electrodes play a critical role in capturing neural signals, while sensors ensure accurate data acquisition. Also, amplifiers strengthen and process these signals for analysis. The signal processing units interpret the neural data, and output devices convey the feedback or actions generated by the BCI system. Moreover, continuous advancements in hardware technology, miniaturisation, and material improvements are enhancing the efficiency, comfort, and durability of BCIs, contributing to the overall growth and adoption of BCIs across various applications and industries.
Asia Pacific commanded the largest market share during the extrapolated period. The Asia-Pacific region's brain computer interface market is expanding as a result of increasing government funding and considerable research being done to find treatments for diseases and damage to the brain. Additionally, the availability of affordable manufacturing locations and alluring tax policies have enticed foreign corporations to invest in this lucrative sector in Asian nations. This has significantly encouraged the industry for brain-computer interfaces to expand in this area. Furthermore, the rising number of collaborations among BCI market players across Asia Pacific region is ultimately evolving the growth of the brain computer interface market.
North America is expected to witness profitable growth over the projection period. R&D and clinical trial investigations for brain-computer interface (BCI) technologies are heavily pursued in North American countries. High R&D spending, the creation of cutting-edge infrastructure, and the effective use of cutting-edge technology are a few of the primary reasons fostering the expansion of the brain-computer interface market in the North American region. The incidence of neurological disorders like Parkinson's, Huntington's disease, and Alzheimer's is also projected to spur market expansion. Additionally, as cutting-edge technology like improved brain-computer interfaces develops, the popularity and demand for realistic gaming are projected to rise. This will hasten the adoption of BCI technologies in the United States, Canada, and other North American nations.
Some of the key players in the Brain Computer Interface Market include: Mind Technologies Inc., Compumedics, Ltd., Covidien, PLC, Natus Medical, Inc., Integra Life Sciences Corporation, Nihon Kohden Corporation, CAS Medical Systems, Advanced Brain Monitoring Inc., G.Tec Medical Engineering Gmbh, Integra Lifesciences Corporation, Brain Products Gmbh, Neurosky, Neuroelectrics, Nirx Medical Technologies, LLC, Ripple Neuro, Cadwell Industries, Cortech Solutions Inc, Natus Medical Incorporated, Emotiv Inc. and Medtronic.
In May 2023, Neuralink secured elusive FDA approval to initiate human trials of their brain-computer interface technology.
In January 2023, MicroCloud Hologram Inc., a provider of Hologram Digital Twins Technology, announced the release of their holographic BCI data collecting system. The holographic BCI data acquisition system from HOLO combines BCI and holographic technology, allowing the two technologies to complement one another. Holographic technology can be used to provide more realistic, rich, and stimulating contextual feedback for a more immersive user experience in BCI systems.